Clinical Study to Evaluate Nesiritide in Patients Undergoing Coronary Artery Bypass Graft (CABG) Surgery A014 / NAPA

NCT00653042 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

305

Enrollment

INDUSTRY

Sponsor class

Conditions

Coronary Artery Bypass Surgery
Coronary Heart Disease
Coronary Artery Bypass Grafting
Cardiopulmonary Bypass
Ischemic Heart Disease
Congestive Heart Failure

Interventions

DRUG: Nesiritide

Sponsor

Scios, Inc.